1. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
   Zhihuai Wang et al, 2021, BioMed Research International CrossRef
2. Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
   Yingkun Xu et al, 2022, BioMed Research International CrossRef
3. Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery
   Peng Han et al, 2021, PeerJ CrossRef
4. Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
   Shan-Shan Jiang et al, 2021, Frontiers in Molecular Biosciences CrossRef
5. Long Noncoding RNA LINC00707 Accelerates Tumorigenesis and Progression of Bladder Cancer via Targeting miR-145/CDCA3 Regulatory Loop
   Tongbin Gao et al, 2021, Urologia Internationalis CrossRef
6. Prognostic value of CDCA3 in kidney renal papillary cell carcinoma
   Hao Li et al, 2021, Aging CrossRef
7. Bioinformatic Analysis for Influential Core Gene Identification and Prognostic Significance in Advanced Serous Ovarian Carcinoma
   Changho Song et al, 2021, Medicina CrossRef
8. LncCDCA3L inhibits cell proliferation via a novel RNA structure‐based crosstalk with CDCA3 in hepatocellular carcinoma
   Yongfeng Wang et al, 2022, Liver International CrossRef
9. CDCA3 Predicts Poor Prognosis and Affects CD8+ T Cell Infiltration in Renal Cell Carcinoma
   Yuanyuan Bai et al, 2022, Journal of Oncology CrossRef